Aquestive Therapeutics
AQST
AQST
35 hedge funds and large institutions have $43.2M invested in Aquestive Therapeutics in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less capital invested
Capital invested by funds: $61M → $43.2M (-$17.8M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$284K | |
| 2 | +$155K | |
| 3 | +$133K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$94K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$90K |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$571K | |
| 3 | -$528K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$266K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$213K |